Effective salvage therapy for refractory disseminated breast cancer with 5-fluorouracil and high-dose continuous infusion folinic acid. 1988

J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
Department of Medical Oncology, City of Hope Cancer Research Center, Duarte, California.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002955 Leucovorin The active metabolite of FOLIC ACID. Leucovorin is used principally as an antidote to FOLIC ACID ANTAGONISTS. Calcium Leucovorin,Citrovorum Factor,Folinic Acid,N(5)-Formyltetrahydrofolate,5-Formyltetrahydrofolate,5-Formyltetrahydropteroylglutamate,Calcium Folinate,Folinic Acid-SF,Leucovorin, (D)-Isomer,Leucovorin, (DL)-Isomer,Leucovorin, (R)-Isomer,Leucovorin, Calcium (1:1) Salt,Leucovorin, Calcium (1:1) Salt, (DL)-Isomer,Leucovorin, Calcium (1:1) Salt, Pentahydrate,Leucovorin, Monosodium Salt,Leukovorin,Leukovorum,Wellcovorin,5 Formyltetrahydrofolate,5 Formyltetrahydropteroylglutamate,Acid, Folinic,Factor, Citrovorum,Folinate, Calcium,Folinic Acid SF,Leucovorin, Calcium,Monosodium Salt Leucovorin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D005472 Fluorouracil A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid. 5-FU,5-FU Lederle,5-FU Medac,5-Fluorouracil,5-Fluorouracil-Biosyn,5-HU Hexal,5FU,Adrucil,Carac,Efudex,Efudix,Fluoro-Uracile ICN,Fluoroplex,Fluorouracil Mononitrate,Fluorouracil Monopotassium Salt,Fluorouracil Monosodium Salt,Fluorouracil Potassium Salt,Fluorouracil-GRY,Fluorouracile Dakota,Fluorouracilo Ferrer Far,Fluoruracil,Fluracedyl,Flurodex,Haemato-FU,Neofluor,Onkofluor,Ribofluor,5 FU Lederle,5 FU Medac,5 Fluorouracil,5 Fluorouracil Biosyn,5 HU Hexal,Dakota, Fluorouracile,Fluoro Uracile ICN,Fluorouracil GRY,Haemato FU

Related Publications

J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
January 1988, Cancer investigation,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
October 1995, Cancer,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
September 1988, European journal of cancer & clinical oncology,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
January 1987, Oncology,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
April 1988, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
December 2002, Zeitschrift fur Gastroenterologie,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
March 1991, Annals of oncology : official journal of the European Society for Medical Oncology,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
November 1994, Annals of oncology : official journal of the European Society for Medical Oncology,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
January 1995, Oncology,
J H Doroshow, and L Leong, and K Margolin, and B Flanagan, and D Goldberg, and M Bertrand, and S Akman, and B Carr, and O Odujinrin, and T Litchfield
April 1985, Chemioterapia : international journal of the Mediterranean Society of Chemotherapy,
Copied contents to your clipboard!